News Conference News TCT 2018 More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses Michael O'Riordan September 24, 2018
News Conference News TCT 2018 OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients Todd Neale September 24, 2018
Presentation TCT 2018 GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Patrick W. Serruys September 24, 2018
Presentation TCT 2018 Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement? Presenter: Deepak L. Bhatt, Tullio Palmerini, Usman Baber September 23, 2018
Presentation TCT 2018 How Strong are the Pharmacodynamic Data and Clinical Evidence for Crushed Ticagrelor and Prasugrel? Presenter: John A. Bittl, C. Michael Gibson, Dimitrios Alexopoulos September 23, 2018
News Conference News TCT 2018 ReCre8: Physician-Led Study Shows Noninferiority of Polymer-Free Stent Compared With Permanent-Polymer ZES at 1 Year Yael L. Maxwell September 22, 2018
Presentation TCT 2018 Clinical Trials for Short DAPT: FDA Perspective Presenter: Christopher J Popma September 22, 2018
News Conference News TCT 2018 EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis Michael O'Riordan September 21, 2018
Presentation TCT 2018 TCT-112: Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Event in the Global Leaders Trial Presenter: George D. Dangas, Germano Di Sciascio, Patrick W. Serruys September 21, 2018
News Conference News TCT 2017 Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used Todd Neale November 02, 2017
Presentation TCT 2017 Adjunctive Pharmacotherapy During and After TAVR: Current Trends, New Studies, and the Case for Short-term (3-6 months) Systemic Anticoagulation Presenter: Eberhard Grube, James B. Hermiller Jr., Pascal Vranckx November 01, 2017
Presentation TCT 2017 Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial) Presenter: Samir R. Kapadia November 01, 2017
Presentation TCT 2017 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice Presenter: Deepak L. Bhatt, C. Michael Gibson November 01, 2017
Presentation TCT 2017 REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS Presenter: Robert A. Harrington, Gregg W. Stone, Harry Suryapranata November 01, 2017
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Three Shelley Wood November 01, 2017
Presentation TCT 2017 DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI Presenter: Robert A. Harrington, Gregg W. Stone, Elvin Kedhi November 01, 2017
Presentation TCT 2017 SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years Presenter: Robert A. Harrington, Gregg W. Stone, Olivier Varenne November 01, 2017
Presentation TCT 2017 Adjunctive Pharmacotherapy after TAVR Settled and Unsettled Issues Presenter: Charles J. Davidson, Mathew Williams, Luis Nombela-Franco November 01, 2017
Presentation TCT 2017 What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis Presenter: Azeem Latib, Gregg W. Stone October 31, 2017
Presentation TCT 2017 FDA Perspectives on Short DAPT IDE Trials Presenter: Mitchell W. Krucoff, P.F. Adrian Magee October 31, 2017